These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 11028111

  • 1. Pilocarpine in the prevention of postirradiation xerostomia.
    Lajtman Z, Krajina Z, Krpan D, Vincelj J, Borcić V, Popović-Kovacić J.
    Acta Med Croatica; 2000; 54(2):65-7. PubMed ID: 11028111
    [Abstract] [Full Text] [Related]

  • 2. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
    Scarantino C, LeVeque F, Swann RS, White R, Schulsinger A, Hodson DI, Meredith R, Foote R, Brachman D, Lee N.
    J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
    [Abstract] [Full Text] [Related]

  • 3. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction.
    Valdez IH, Wolff A, Atkinson JC, Macynski AA, Fox PC.
    Cancer; 1993 Mar 01; 71(5):1848-51. PubMed ID: 8448748
    [Abstract] [Full Text] [Related]

  • 4. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
    Sangthawan D, Watthanaarpornchai S, Phungrassami T.
    J Med Assoc Thai; 2001 Feb 01; 84(2):195-203. PubMed ID: 11336078
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
    Burlage FR, Roesink JM, Kampinga HH, Coppes RP, Terhaard C, Langendijk JA, van Luijk P, Stokman MA, Vissink A.
    Int J Radiat Oncol Biol Phys; 2008 Jan 01; 70(1):14-22. PubMed ID: 17869018
    [Abstract] [Full Text] [Related]

  • 7. Radiation-induced xerostomia: how dry is your patient?
    Bruce SD.
    Clin J Oncol Nurs; 2004 Feb 01; 8(1):61-7. PubMed ID: 14983765
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia.
    Jha N, Seikaly H, Harris J, Williams D, Sultanem K, Hier M, Ghosh S, Black M, Butler J, Sutherland D, Kerr P, Barnaby P.
    Head Neck; 2009 Feb 01; 31(2):234-43. PubMed ID: 19107948
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Drug used during radiotherapy helps reduce dry mouth problem.
    Expert Rev Anticancer Ther; 2001 Jun 01; 1(1):4. PubMed ID: 12113130
    [No Abstract] [Full Text] [Related]

  • 12. Functional outcomes related to the prevention of radiation-induced xerostomia: oral pilocarpine versus submandibular salivary gland transfer.
    Rieger JM, Jha N, Lam Tang JA, Harris J, Seikaly H.
    Head Neck; 2012 Feb 01; 34(2):168-74. PubMed ID: 21416547
    [Abstract] [Full Text] [Related]

  • 13. Oral pilocarpine (5mg t.i.d.) used for xerostomia causes adverse effects in Japanese.
    Nakamura N, Sasano N, Yamashita H, Igaki H, Shiraishi K, Terahara A, Asakage T, Nakao K, Ebihara Y, Ohtomo K, Nakagawa K.
    Auris Nasus Larynx; 2009 Jun 01; 36(3):310-3. PubMed ID: 18635328
    [Abstract] [Full Text] [Related]

  • 14. Pilocarpine treatment of xerostomia in head and neck patients.
    Leek H, Albertsson M.
    Micron; 2002 Jun 01; 33(2):153-5. PubMed ID: 11567884
    [Abstract] [Full Text] [Related]

  • 15. Effect of oral pilocarpine on post-irradiation xerostomia in head and neck cancer patients: a single-center, single-blind clinical trial.
    Chitapanarux I, Kamnerdsupaphon P, Tharavichitkul E, Sumitsawan Y, Sittitrai P, Pattarasakulchai T, Lorvidhaya V, Sukthomya V, Pukanhaphan N, Traisatit P.
    J Med Assoc Thai; 2008 Sep 01; 91(9):1410-5. PubMed ID: 18843872
    [Abstract] [Full Text] [Related]

  • 16. Oral pilocarpine: new preparation. Xerostomia after radiation therapy: moderately effective but costly.
    Prescrire Int; 2002 Aug 01; 11(60):99-101. PubMed ID: 12199276
    [Abstract] [Full Text] [Related]

  • 17. The influence of pilocarpine and biperiden on pH value and calcium, phosphate, and bicarbonate concentrations in saliva during and after radiotherapy for head and neck cancer.
    Rode M, smid L, Budihna M, Gassperssic D, Rode M, Soba E.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Nov 01; 92(5):509-14. PubMed ID: 11709686
    [Abstract] [Full Text] [Related]

  • 18. Prevention of oral and salivary gland impairment in irradiated adolescent patients with head and neck cancer: a suggested protocol.
    Davidovich E, Peretz B, Aframian DJ.
    Quintessence Int; 2007 Mar 01; 38(3):235-9. PubMed ID: 17334001
    [Abstract] [Full Text] [Related]

  • 19. Effect of 0.1% pilocarpine mouthwash on xerostomia: double-blind, randomised controlled trial.
    Kim JH, Ahn HJ, Choi JH, Jung DW, Kwon JS.
    J Oral Rehabil; 2014 Mar 01; 41(3):226-35. PubMed ID: 24527846
    [Abstract] [Full Text] [Related]

  • 20. Salivary scintigraphy for assessing the protective effect of pilocarpine in head and neck irradiated tumours.
    Mateos JJ, Setoain X, Ferre J, Rovirosa A, Navalpotro B, Martin F, Ortega M, Lomeña F, Fuster D, Pavia J, Pons F.
    Nucl Med Commun; 2001 Jun 01; 22(6):651-6. PubMed ID: 11403176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.